EditForce, Inc. - New Tools Lead to a New World

エディットフォース株式会社

Innovative gene therapy
with Japan's novel
RNA-editing technology

New Tools Lead to a New World

See our strength

news

2024.01.31

information
EditForce achieved selective enhancement of translation from target mRNA in human cells using programmable RNA-binding PPR proteins

2024.01.31

information
EditForce picked in "National Vision for Engineering Biology", published by UK Government

2023.10.19

information
EditForce Won Elsevier WMS Membership Award at World Muscle Society 2023

2023.09.16

information
EditForce Participated in Rett Syndrome Genetic Medicines Summit

2023.06.01

information
RELOCATION OF HEADQUARTERS
See other news

our work

Utilizing our proprietary RNA editing technology, we will establish a new global standard in various fields such as drug discovery, chemicals, and agriculture.

私たちの強み

Strength

We are a Japan's startup based on the novel RNA-editing technology.

See details

開発技術

Technology

We are striving to establish a global standard of gene editing with the unique approach.

See details

創薬プログラム

Program

We are applying our proprietary RNA-editing technology to drug discovery.

See details

company

We have developed an innovative gene control technology based on the mechanism of RNA editing by PPR proteins in plant and are now applying it to drug discovery to establish new modality for various diseases.

Beginning with drug discovery, we aim to create novel values in various fields such as chemicals and agriculture.

エディットフォースの事業

See more about us

エディットフォースの事業

contact

Feel free to contact us when you have any questions or concerns.

Contact
MENU
PAGE TOP